|
FR2797585A1
|
|
Composition for topical administration comprising 5-methoxypsoralene
|
|
FR2747017A1
|
|
Dietary supplement
|
|
FR2700545A1
|
|
Method for assaying furocoumarins, and more particularly psoralen and its derivatives, compounds and kits for the implementation of this method.
|
|
FR2698270A1
|
|
Use of 5-methoxypsoralen in the treatment of AIDS.
|
|
FR2695036A1
|
|
Oil containing 5-methoxypsoralen at a concentration of 60 to 100 PPM and its use for the treatment of psoriasis.
|
|
US5360816A
|
|
5-methoxy psoralen used to treat psoriasis
|
|
US5200425A
|
|
Drugs containing a psoralene derivative
|
|
FR2662352A1
|
|
Hygiene and health products for gencives based on elastine peptides.
|
|
US4939167A
|
|
Use of 5-methoxypsoralen and other furocoumarins as jet lag suppressants
|
|
FR2630005A1
|
|
New anti-depressant medicine containing 5-methoxypsoralene
|
|
GR80733B
|
|
Composition for the periodontosis, gum and tooth hygiene
|
|
FR2556967A1
|
|
Composition for hygiene and health of periodonte, gencives and teeth
|
|
IT8321216D0
|
|
5-Methoxy-psoralen for epidermal cell proliferation tumours
|
|
FR2524801A1
|
|
Drugs containing a psoralene derivative
|
|
CA1130302A
|
|
5-methoxy-psoralen as new medicament and process for the synthesis thereof
|
|
US4284650A
|
|
Composition for chewing gums
|
|
IT7923089D0
|
|
8-Hydroxy quinoline deodorising agent - used in powder, cream, gel or soln. compsns.
|
|
DE2917729A1
|
|
DEODORIZING AGENT
|
|
IT7828971D0
|
|
5-Methoxy-psoralen for psoriasis treatment - prepd. from phloroglucinol via mono-methyl ether, 6-hydroxy-4-methoxy-coumaran-3-one and coumaran
|
|
EP0001733A1
|
|
5-Methoxy-psoralene as a new medicament and process for the synthesis
|
